Karl Mandarano

Experience

• 

  Boehringer Ingelheim Pharmaceuticals

  Jan 2005 - Jul 2016

  • Provided education and expertise to Hospital, Military and VA Ecosystems• Promoted to Senior Institutional Consultant after multiple President's Club awards • Promoted Neurology (Aggrenox/Mirapex) and Urology (Flomax) medicines to office-based specialists

  • Senior Institutional Consultant/Senior Institutional Account Specialist

    Apr 2008 - Jul 2016

  • Specialty Sales Representative, Neurology | Urology

    Jan 2005 - Mar 2008
• 

  Novartis

  Aug 2016 - now

  • Provided disease-state education then launched novel injectable medication Aimovig to market in May 2018• Sold to influential Neurologist and Pain Management Specialists• Achieved consistently high rankings each sales year • Promoted Gilenya to Multiple Sclerosis Specialists and Centers of Excellence• Achieved MS Scholar Status

  • Migraine Executive Sales Specialist

    Jan 2018 - now

  • Multiple Sclerosis Executive Sales Specialist

    Aug 2016 - Dec 2017
• 

  Mallinckrodt Pharmaceuticals

  Jan 2022 - now

  Acute Care Business Manager

  Focus on Rare Disease- Liver in the Hospital & Specialist Office Space- key influential institutionsinclude 3 Liver Transplant Centers in North and Central Florida• September 2022- Launched Terlivaz, a new FDA-approved medicine indicated to treat adults with Hepatorenal Syndrome• January 2022 to August 2022- Focused on Disease-State Awareness Education in Major Institutions- multi-disciplinary educational approach included Hepatology/Nephrology/Intensivist/Hospitalist/Pharmacy Specialists Show less